Titre:
  • A phase 3 randomized trial comparing inolimomab vs usual care in steroid-resistant acute GVHD
Auteur:Socié, Gérard; Gard, Philippe; Medeghri, Zakaria; Lehert, Philippe; Lai, Chinglin; Corn, Tim; Vernant, Jean Paul; Vigouroux, Stéphane; Yakoub-Agha, Ibrahim; Bay, Jacques Olivier; Fürst, Sabine; Bilger, Karin; Suarez, Felipe; Michallet, Mauricette; Bron, Dominique
Informations sur la publication:Blood, 129, 5, page (643-649)
Statut de publication:Publié, 2017-02
Sujet CREF:Hématologie
MeSH keywords:Acute Disease
Adult
Antibodies, Monoclonal -- adverse effects -- therapeutic use
Antilymphocyte Serum -- adverse effects -- therapeutic use
Drug Resistance
Female
Graft vs Host Disease -- drug therapy
Humans
Immunosuppressive Agents -- adverse effects -- therapeutic use
Male
Middle Aged
Proportional Hazards Models
Steroids -- therapeutic use
Survival Analysis
Treatment Outcome
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:0006-4971
info:doi/10.1182/blood-2016-09-738625
info:pii/blood-2016-09-738625
info:scp/85014848812
info:pmid/27899357